Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations.
Hou MM, Huang SF, Kuo HP, Yang CT, Tsai YH, Yu CT, Lin HC, Chen CH, Wang CL, Chung FT, Hsieh JJ, Hsu T, Cheng HY, Ou LY, Wang HM, Lin YC, Chang NJ, Chang JW.
Hou MM, et al.
Anticancer Res. 2012 Mar;32(3):1107-12.
Anticancer Res. 2012.
PMID: 22399641